miR-101-3p/Rap1b signal pathway plays a key role in osteoclast differentiation after treatment with bisphosphonates
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Bisphosphonates are the mainstay of therapy worldwide for osteoporosis. However, bisphosphonates also have limitations. The objective of this study was to determine the role of miR-101-3p/Rap1b signal pathway in osteoclast differentiation after treatment with bisphosphonates. Our results revealed that miR-101-3p was an important regulator in bisphosphonates treated-osteoclasts. When miR-101-3p was down-regulated in bone marrow-derived macrophage-like cells (BMMs), the development of mature osteoclasts was promoted, and vice versa. However, alendronate decreased multinucleated cell number regardless of whether miR-101-3p was knocked down or over-expressed. TRAP activity assay confirmed the above results. Luciferase assay indicated that miR-101-3p was a negative regulator of Rap1b. Western blot analysis revealed that protein expression level of Rap1b in BMMs transfected with OV-miR-101-3p was lower than that in BMMs transfected with an empty vector. Rap1b overexpression increased TRAP-positive multinucleated cells, while Rap1b inhibition decreased the cell numbers. In vivo data showed that miR-101-3p inhibited osteoclast differentiation in ovariectomized mice while overexpressed of Rap1b blocked the differentiation. Taken together, our data demonstrate that miR-101-3p/Rap1b signal pathway plays a key role in osteoclast differentiation after treatment with bisphosphonates.
Abstract
Bisphosphonates are the mainstay of therapy worldwide for osteoporosis. However, bisphosphonates also have limitations. The objective of this study was to determine the role of miR-101-3p/Rap1b signal pathway in osteoclast differentiation after treatment with bisphosphonates. Our results revealed that miR-101-3p was an important regulator in bisphosphonates treated-osteoclasts. When miR-101-3p was down-regulated in bone marrow-derived macrophage-like cells (BMMs), the development of mature osteoclasts was promoted, and vice versa. However, alendronate decreased multinucleated cell number regardless of whether miR-101-3p was knocked down or over-expressed. TRAP activity assay confirmed the above results. Luciferase assay indicated that miR-101-3p was a negative regulator of Rap1b. Western blot analysis revealed that protein expression level of Rap1b in BMMs transfected with OV-miR-101-3p was lower than that in BMMs transfected with an empty vector. Rap1b overexpression increased TRAP-positive multinucleated cells, while Rap1b inhibition decreased the cell numbers. In vivo data showed that miR-101-3p inhibited osteoclast differentiation in ovariectomized mice while overexpressed of Rap1b blocked the differentiation. Taken together, our data demonstrate that miR-101-3p/Rap1b signal pathway plays a key role in osteoclast differentiation after treatment with bisphosphonates.
참고문헌 (24)
- Johnell O, "An estimate of the worldwide prevalence and disability associated with osteoporotic fractures", Osteoporos Int, 17, pp.1726~1733 (2006)
- Ji X, "MicroRNAs in Osteoclastogenesis and Function : Potential Therapeutic Targets for Osteoporosis", Int J Mol Sci, 17, pp.349~ (2016)
- Yuen T, "Bisphosphonates inactivate human EGFRs to exert antitumor actions", Proc Natl Acad Sci U S A, 111, pp.17989~17994 (2014)
- Soares AP, "Bisphosphonates : Pharmacokinetics, bioavailability, mechanisms of action, clinical applications in children, and effects on tooth development", Environ Toxicol Pharmacol, 42, pp.212~217 (2016)
- Fordham JB, "MiR-142-3p is a RANKL-dependent inducer of cell death in osteoclasts", Sci Rep, 6, pp.24980~ (2016)
- Hu CH, "miR-21 deficiency inhibits osteoclast function and prevents bone loss in mice", Sci Rep, 7, pp.43191~ (2017)
- Ke K, "MicroRNA-183 increases osteoclastogenesis by repressing heme oxygenase-1", Bone, 81, pp.237~246 (2015)
- Sang S, "MicroRNA-16-5p Inhibits Osteoclastogenesis in Giant Cell Tumor of Bone", Biomed Res Int, 2017, pp.3173547~ (2017)
- X.H. Zhang, "MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting", Genetics and Molecular Research, 15(3) (2016), Genetics and Molecular Research[DOI]
- Lee D, "Inhibition of Osteoclast Differentiation and Bone Resorption by Bisphosphonate-conjugated Gold Nanoparticles", Sci Rep, 6, pp.27336~ (2016)
- Subramanian A, "Gene set enrichment analysis : a knowledge-based approach for interpreting genome-wide expression profiles", Proc Natl Acad Sci U S A, 102, pp.15545~15550 (2005)
- Bindea G, "CluePedia Cytoscape plugin : pathway insights using integrated experimental and in silico data", Bioinformatics, 29, pp.661~663 (2013)
- Bindea G, "ClueGO : a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks", Bioinformatics, 25, pp.1091~1093 (2009)
- Kohl M, "Cytoscape : software for visualization and analysis of biological networks", Methods Mol Biol, 696, pp.291~303 (2011)
- Liu J, "Osteoclastic miR-214targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer", Sci Rep, 7, pp.40487~ (2017)
- Zhao C, "miR-214 promotes osteoclastogenesis by targeting Pten", PI3k, RNA Biol, pp.2015, 12[DOI]
- Zhang L, "Overexpression of MiR-335-5p Promotes Bone Formation and Regeneration in Mice", J Bone Miner Res, 12, pp.2466~2475 (2017)
- Sheng Y, "Functional analysis of miR-101-3p and Rap1b involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis", Biochem Cell Biol, 92, pp.152~162 (2014)
- Gong J, "Esophageal squamous cell carcinoma cell proliferation induced by exposure to low concentration of cigarette smoke extract is mediated via targeting miR-101-3p", COX-2 pathway, 2016, pp.35, 463~471
- Liu P, "mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK", Oncotarget, 7, pp.35188~35198 (2016)
- Maruyama T, "Rap1b Is an Effector of Axin2 Regulating Crosstalk of Signaling Pathways During Skeletal Development", J Bone Miner Res, 32, pp.1816~1828 (2017)
- Zou W, "Talin1 and Rap1 are critical for osteoclast function", Mol Cell Biol, 33, pp.830~844 (2013)
- Wang H, "MiR-101 Targets the EZH2", Wnt, Sci Rep, pp.2016, 6[DOI]
- Im GI, "Osteoblast proliferation and maturation by bisphosphonates", Biomaterials, 25, pp.4105~4115 (2004)